Roland Wilhelm Kolbeck

Insider Reports History

Location
Wayne, PA
Signature
/s/ Matthew Rothman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Roland Wilhelm Kolbeck:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aclaris Therapeutics, Inc. Chief Scientific Officer Employee Stock Option (Right to Buy) 334,900 02 Feb 2026 Direct
Aclaris Therapeutics, Inc. Chief Scientific Officer Restricted Stock Units 95,700 02 Feb 2026 Direct

Insider Reports Filed by Roland Wilhelm Kolbeck

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACRS Aclaris Therapeutics, Inc. 02 Feb 2026 2 $0 4 Chief Scientific Officer 06 Feb 2026, 18:06
ACRS Aclaris Therapeutics, Inc. 01 Aug 2025 2 $0 4 Chief Scientific Officer 05 Aug 2025, 16:33
ACRS Aclaris Therapeutics, Inc. 28 Jul 2025 0 $0 3 Chief Scientific Officer 05 Aug 2025, 16:31